Microgard

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Microgard

Quick Facts

Property Description
Active ingredient Chlorhexidine Gluconate and Cetrimide
Form Topical Solution (Liquid)
Pharmacological Class Antiseptic and Germicide
Common Use Hygienic Skin Disinfection
Origin Synthetic (Combination Product)

What is Microgard and Its Pharmacological Identity?

Microgard is a medicated antiseptic and antimicrobial preparation formulated as a topical solution intended exclusively for external use on the skin. It belongs to the high-level pharmacological category of Antiseptics and germicides, a class of agents applied to living tissue to reduce the possibility of infection, sepsis, or putrefaction. The primary component, Chlorhexidine, is an essential medicine for basic health systems, characterized by its role in antimicrobial action. Microgard is classified as a synthetic and combination product, a feature that supports its broad-spectrum action crucial for prophylactic hygiene applications, distinguishing it from simpler, single-agent antiseptic washes.

Composition and Pharmaceutical Form of Microgard Solution

Microgard's composition features two key active ingredients: Chlorhexidine Gluconate (a biguanide compound) and Cetrimide (a quaternary ammonium preservative), suspended in an aqueous or alcohol-based solution vehicle. The combination of Chlorhexidine Gluconate and Cetrimide exhibits synergistic antimicrobial and antibiofilm potential. This synergistic action means the components enhance each other's effectiveness in controlling pathogens. The preparation is presented exclusively as a topical solution for application to skin. This dual-ingredient composition is specifically engineered to leverage the Cetrimide component for cleansing the skin while simultaneously enhancing the penetration and efficacy of the principal antiseptic, Chlorhexidine Gluconate.

General Purpose: What is Microgard Used for?

The general purpose of Microgard is to provide broad-spectrum antimicrobial activity for prophylactic use, supporting infection control efforts through effective skin disinfection and hygienic washing. It is utilized to significantly reduce the quantity of viable infectious microorganisms, including various bacteria, present on the skin and hands. The preparation is specifically designed to enable high-standard hygiene, such as preparatory surgical scrubbing by clinical staff or general antiseptic preparation of intact skin, by lowering the microbial load before potential contamination or procedures.

Regulatory References

  1. World Health Organization (WHO)

What side effects are possible with Microgard?

Possible Side Effects and Safety Information

The safety profile of Microgard, a combination topical antiseptic containing Chlorhexidine Gluconate and Cetrimide, is defined by regulatory agencies based on risks associated with topical exposure and systemic absorption. This information strictly describes officially documented adverse reactions and safety constraints.

Official Adverse Reactions and Risk

Classification Examples of Documented Reactions
Rare Risks Anaphylactic Shock, Severe Generalized Hypersensitivity Reactions (may include bronchospasm, hypotension, circulatory collapse).
Localized Effects Skin irritation, contact dermatitis, pruritus (itching), erythema (redness), and urticaria (hives).

The most serious documented risk is the potential for anaphylactic shock, which is classified as rare. More commonly, the product may cause localized skin reactions (Skin and Subcutaneous Tissue Disorders); however, the frequency of these effects is generally documented as Not Known in regulatory reports.

Safety Restrictions and Special Populations

Regulatory documentation mandates strict constraints on use to prevent serious injury to specific anatomical sites and populations:

  • Anatomical Contraindications: The solution is strictly prohibited from contact with the eye (risk of severe corneal injury), the middle ear (risk of ototoxicity), and tissues of the central nervous system, such as the meninges or brain (risk of neurotoxicity).
  • Vulnerable Populations: Particular caution is required when using the solution for antisepsis in premature infants and neonates, where there is an officially documented risk of chemical burns.
  • Application Constraints: The product must not be allowed to pool in skin folds or beneath the body during application. Its efficacy can be reduced by interaction with soaps and other anionic agents.

Overdose and Emergency Response

The official regulatory profile for Microgard addresses two primary overdose risks: accidental ingestion and life-threatening hypersensitivity. Accidental ingestion can lead to systemic toxicity, presenting with gastric distress (nausea, abdominal pain) and, depending on the formulation, signs of alcohol intoxication. Documented severe manifestations affect the Central Nervous System, including coma and convulsions, and the Cardiovascular System, marked by hypotension and tachycardia. A life-threatening outcome noted in regulatory texts is respiratory paralysis due to the Cetrimide component. Small children are specifically highlighted as a population at risk for toxicity following ingestion.

Immediate medical attention must be sought for any suspected accidental overdose. Additionally, if signs of severe or life-threatening hypersensitivity (such as anaphylaxis, swelling, or difficulty breathing) develop, individuals must call emergency services. Management is described as symptomatic and supportive treatment because no specific antidote is known. Procedurally, vomiting should be avoided in cases of ingestion of high concentrations. Accidental ocular contact also mandates medical evaluation due to the risk of irreversible injury.

Therapeutic Uses of Microgard

The core therapeutic domain of Microgard is general topical antisepsis, applied across domains where additional symptomatic support is needed, primarily focusing on maintaining skin hygiene. The combination solution is applicable within clinical settings that involve acute or disruptive symptom patterns. The solution is utilized as a general antiseptic, relevant for the cleaning and disinfecting of wounds and the antiseptic treatment of burns.

Microgard is commonly used across conditions presenting with acute episodes, relevant for managing minor trauma and superficial breaks in the skin, including cuts, scrapes, and superficial burns. This action is relevant for easing symptoms related to inflammatory or irritative states and is often used when short-term symptomatic assistance is needed.

“The solution supports patients during episodes of heightened discomfort and contributes to improved day-to-day comfort during symptomatic periods.”

In clinical settings, the preparation is often used during phases when symptoms become more noticeable, particularly for preoperative skin preparation and for managing contaminated or dirty wounds. This is commonly used when short-term symptomatic assistance is needed and may help patients cope more steadily with symptom fluctuations.

Quick Fact: Support for Localized Discomfort
Primary Indication Minor cuts, abrasions, superficial burns, and wound cleansing.
Symptomatic Benefit Easing discomfort associated with inflammation (redness, swelling).
Core Use Context Post-traumatic injury care and pre-operative antisepsis.
Patient Benefit Supports maintenance of functional stability and comfort.

Regulatory References

  1. New Zealand Medsafe Data Sheet

Eligibility and Restrictions for Use

The eligibility profile for Microgard (Chlorhexidine Gluconate and Cetrimide topical solution) is strictly defined by regulatory documentation concerning specific population restrictions and absolute contraindications.

Eligibility Status Restriction or Condition
Contraindicated Known hypersensitivity to Chlorhexidine Gluconate, Cetrimide, or any excipient.
Contraindicated Application near the meninges, brain, spinal cord, or in the eye.
Contraindicated Use in the auditory canal if the eardrum is perforated.
Not Recommended Infants younger than 2 months of age (risk of chemical burns/absorption).
Use with Caution Premature infants and application to large open wounds.

The medicine is generally suitable for topical use by adults and children over two months of age. Absolute non-eligibility also applies to the route of administration; the solution must not be used intravenously or taken orally. For pregnancy and lactation, official labeling notes that no adequate data are available for safe use in pregnant women, and it is unknown whether the active ingredients are excreted in breast milk. No specific restrictions are established for patients with hepatic or renal impairment.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Microgard’s official interaction profile is defined by local physicochemical incompatibility and specific administration site restrictions, consistent with its classification as a topical antiseptic. Due to the minimal systemic absorption of the active ingredients, Chlorhexidine Gluconate and Cetrimide, government regulatory documents do not list interactions involving drug-metabolizing enzymes (such as CYP450) or transport proteins, and no systemic exposure-modifying interactions are documented.


Physicochemical and Topical Incompatibilities

The solution's antiseptic action is formally documented as being reduced or inactivated upon contact with certain substances. The cationic nature of Chlorhexidine makes it chemically incompatible with anionic substances and anionic detergents, including common soaps. This combination results in a loss of the product’s intended efficacy at the application site. Furthermore, the presence of organic matter, specifically blood or pus (tissue exudates), is also documented to reduce the antiseptic effectiveness of the solution.


Restrictions on Administration Site

The regulatory profile includes a critical, label-based constraint concerning administration. The co-administration of the solution near the meninges or nervous tissue is strictly prohibited. This restriction is documented due to an official risk of neurotoxicity associated with this specific anatomical co-administration, classifying it as a contraindicated combination within the regulatory framework.

Mechanism of Action

Cationic Disruption and Lethal Cascade

The mechanism begins with the electrostatic attraction of the positively charged active components, Chlorhexidine (a biguanide) and Cetrimide (a quaternary ammonium compound), to the negatively charged surface of microorganisms . This binding destabilizes the microbial cell wall and compromises the integrity of the inner cytoplasmic membrane. Physical damage to the membrane leads to the loss of osmotic balance and the efflux of essential cellular components.

Membrane disruption permits Chlorhexidine to penetrate the cell's interior, causing the coagulation and precipitation of vital intracellular contents, including proteins and nucleic acids. This cascade results in a comprehensive bactericidal action, which contributes to the physiological reduction of viable microbial populations. The combination acts synergistically, with Cetrimide enhancing the penetration and action of the principal antiseptic. Furthermore, Chlorhexidine binds strongly to the skin (substantivity), creating a non-systemic reservoir that results in a prolonged physiological modulation of microbial populations at the application site.

Dosage and Administration Information

Microgard is an antiseptic preparation intended strictly for Topical (cutaneous) administration and for Irrigation of wounds and burns. It must never be administered via injection (intravenously) or taken orally. The official pattern of use is not based on a fixed schedule but on an as-needed basis, tied to the clinical requirement for wound cleansing and skin disinfection.

The general principle for application is to use the minimum amount necessary to fully cover the targeted area; the dosage is individualized rather than being a standardized volume. Ready-to-use solutions are applied undiluted, though certain concentrate forms require pre-dilution with water according to specific directions.

Official Procedural Steps

Procedurally, the official instructions define specific steps for proper administration. The skin or wound area must be rinsed thoroughly with water before the solution is applied. The area should be gently washed with the minimum required solution. Following application, the site must be rinsed again thoroughly with water and allowed to air dry.

Specific procedural constraints prohibit the solution from being used for irrigation of the eyes, auditory canal (especially if the eardrum is perforated), or other sensitive internal tissues. The solution must also be used with extreme care in neonates, particularly premature infants, due to the recognized risk of chemical skin burns in this population. Sterile presentations are often marked for single use only, requiring the disposal of any unused remainder.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Microgard

The research base for Microgard (Chlorhexidine Gluconate and Cetrimide topical solution) is composed of studies that explore the patterns related to antisepsis of the combination, alongside extensive, high-level evidence supporting the principal active component, Chlorhexidine. This overview describes the research that has been conducted and what remains uncertain, without providing any guidance on usage.


Evidence for Use in Preoperative Skin Disinfection

Research was evaluated in settings where infection prevention is critical. High-level Systematic Reviews and Randomized Controlled Trials (RCTs) explored how the use of the principal antiseptic component was associated with patterns related to microbial load and the incidence of surgical site infections (SSIs) in surgical settings. Studies monitoring large adult populations reported how symptoms evolved in the observed populations, noting data show patterns related to the incidence of SSI. However, the majority of the highest-quality comparative evidence focuses on Chlorhexidine-alcohol formulations, meaning that the research for the specific Chlorhexidine-Cetrimide combination is less frequent in established systematic reviews.


Evidence for Use in Wound and Cut Cleansing

The research was evaluated in settings related to wound and cut cleansing, relying more heavily on In-vitro (laboratory) studies that precisely measured the solution’s patterns related to antisepsis against common bacteria and fungi. Laboratory tests described patterns observed in the studies, such as antimicrobial action between the two active ingredients, which research describes as a change in microbial counts. What remains uncertain is how the solution was associated with the body's natural healing processes. Scientific reviews have noted that existing clinical studies provide limited insight into the solution's impact on the speed or quality of long-term wound healing over several weeks.


What Remains Uncertain About the Research Base

One key research limitation is that comparative evidence is lacking for the specific Chlorhexidine-Cetrimide solution in certain high-level systematic reviews. Additionally, while the solution was studied for patterns related to antisepsis, data for certain groups remain insufficient, and follow-up durations were limited when assessing effects on chronic wound care. Research describes areas where certainty remains low regarding the potential influence of the solution on the cellular processes involved in wound healing.

Key Studies & References

  1. A Randomized Trial Comparing Skin Antiseptic Agents at Cesarean Delivery
  2. Residual Effect of Chlorhexidine-alcohol Compared to Triclosan-alcohol
  3. Revisiting the Synergistic In Vitro Antimicrobial and Antibiofilm Potential of Chlorhexidine Gluconate and Cetrimide in Combination as an Antiseptic and Disinfectant Agent
  4. Chlorhexidine and Cetrimide Irrigation Solution - New Zealand Medsafe Data Sheet
  5. Wound management – Chlorhexidine: A WHAM evidence summary (Focus on Burns/Pain)

Frequently Asked Questions (FAQ)

Common questions about Microgard (FAQ)

Q: What does it mean that Microgard is a 'prophylactic' medicine?

Microgard is officially described as providing broad-spectrum antimicrobial activity for prophylactic use. In this context, prophylactic means that the medicine is used to prevent the development of infection or disease, such as through the disinfection of skin and wounds.

Q: How quickly does Microgard start working after taking it?

Studies and official information indicate that the active ingredients, Chlorhexidine and Cetrimide, disrupt microbial cells rapidly through an electrostatic binding process. This mechanism of action is described as having a fast onset of antimicrobial action at the application site.

Q: What is the duration of action for one dose of Microgard?

The principal active ingredient, Chlorhexidine, is noted to bind strongly to the skin (a property called substantivity). This binding creates a non-systemic reservoir that regulatory information describes as leading to a prolonged physiological modulation of microbial populations at the application site.

Q: Can Microgard be taken by someone who has kidney issues?

Regulatory documents state that no specific restrictions are established for patients with liver or kidney impairment. This is because Microgard is a topical solution with minimal systemic absorption, meaning very little of the active ingredients enters the bloodstream.

Q: Are the side effects of Microgard generally mild or more serious?

The official safety profile includes both rare, serious risks and more common localized effects. The safety profile includes the risk of anaphylactic shock, which official sources classify as rare. More frequently, users may experience localized skin reactions such as irritation, redness, or itching.

Q: Do most people experience weight change while taking Microgard?

Weight change is not listed in the officially documented adverse reactions for this topical solution. Given the minimal systemic absorption, systemic effects like weight change would not be typically expected.

Q: What are the most common reasons a doctor might advise against Microgard?

Official product information lists certain absolute contraindications. These include known hypersensitivity or allergy to any of the ingredients. Application is also strictly prohibited in sensitive areas such as the eye, middle ear, or near nervous tissue (meninges/brain).

Q: Is it true that Microgard can affect sleep patterns?

Changes in sleep patterns are not listed as a documented adverse reaction in regulatory safety documents. This is consistent with the product's classification as a topical antiseptic with minimal absorption into the body's system.

Q: Is Microgard a long-term treatment or is it usually for a short time?

The official pattern of use is defined as an as-needed antiseptic application, tied to the clinical requirement for wound cleansing or skin disinfection. It is not intended to follow a fixed, long-term schedule like certain systemic medications.

Q: What happens if a dose of Microgard is forgotten?

Because Microgard is a topical, as-needed antiseptic, there is no formal concept of a 'missed dose' requiring a fixed make-up application. Use is based on the clinical requirement for disinfection.

Q: Can Microgard be used by older adults (e.g., those over 65)?

No specific restrictions are established for older adults in regulatory documents. While official information mandates particular caution for premature infants and neonates, age over 65 is not listed as a special precaution or contraindication.

Q: What kind of research has been done on Microgard, and where can I find it?

Research has been done on the antiseptic action of the active ingredients in settings like preoperative skin disinfection and wound cleansing. You can typically find details on the research through official government sources that link to scientific literature databases such as PubMed or Clinical Trials.

Q: Is Microgard known to cause dizziness or lightheadedness?

Dizziness or lightheadedness are not listed as documented adverse reactions in official safety profiles for topical use. Systemic effects such as these are not expected due to the minimal absorption of the active ingredients into the body.

Q: Can Microgard be taken at the same time as cold and flu medicines?

Regulatory documents indicate that due to minimal systemic absorption, systemic interactions involving drug-metabolizing enzymes are not listed. Therefore, a systemic interaction with oral cold or flu medicines is not a documented risk.

Q: Does Microgard affect blood pressure readings?

Changes in blood pressure are not listed in the common or localized side effect profile documented in official sources. This is consistent with the product's function as a topical antiseptic with minimal systemic effects.

Q: Is it safe to have alcohol in moderation while on Microgard?

Regulatory documents note that no systemic exposure-modifying interactions with food or alcohol are documented for the topical solution. The active ingredients are primarily absorbed minimally and do not typically interfere with the body's metabolism of oral substances.

Q: Are there different strengths of Microgard available?

Regulatory documents describe the product as a combination of Chlorhexidine Gluconate and Cetrimide. It is typically available in a specific, standard concentration for the solution form, which is intended for its defined use as a topical antiseptic.

Q: Can Microgard interact with birth control pills?

Official information notes the absence of systemic drug-drug interactions involving drug-metabolizing enzymes. Therefore, an interaction with oral hormonal contraceptives is not documented or expected with the topical use of Microgard.

Q: Is Microgard a medicine that has to be taken at a specific time of day?

Official instructions define use on an as-needed basis, tied to the clinical requirement for wound cleansing or disinfection. It is not a medicine that must be applied at a specific time of day or administered on a fixed schedule.

Q: What is the risk of dependence or withdrawal with Microgard?

Dependence or withdrawal symptoms are not listed as documented risks in regulatory safety documents. This is consistent with its classification as a topical antiseptic with minimal systemic effects.

Q: Can Microgard be crushed or split if it's a tablet?

The product is officially described only as a topical solution (liquid) and is not manufactured in tablet form. Therefore, questions about crushing or splitting the product do not apply.

Q: Can Microgard cause changes in mood or anxiety levels?

Changes in mood or anxiety are not listed as documented adverse reactions in official safety profiles for topical use. Such systemic effects are not expected from a topical antiseptic with minimal absorption.

Q: Is Microgard used differently in children compared to adults?

While the expected type and severity of adverse reactions are generally considered similar, official documents mandate particular caution for premature infants and neonates. This is due to an increased risk of chemical burns in this population.

Q: How does Microgard compare to other drugs in its class, conceptually?

Official sources conceptually describe the active ingredient, Chlorhexidine, as having both a fast onset of action and an extended residual activity due to its ability to bind to the skin. This conceptual profile differentiates its action from other antiseptic agents.

Q: Are there common drug-to-drug interactions that are often overlooked with Microgard?

The most critical documented interaction is the physicochemical incompatibility with anionic substances, such as common soaps. This interaction can reduce the antiseptic effectiveness and is often highlighted in administration guidance.

Q: What information should I have ready when discussing Microgard with a healthcare provider?

Official safety warnings indicate that patients should be prepared to discuss any known history of allergies or hypersensitivity to the ingredients. You should also be ready to discuss the use of other topical products or soaps in the application area due to potential incompatibility.

Q: Are there specific symptoms that signal Microgard is working?

The intended action of Microgard is the reduction of viable microorganisms, which is a microbiological outcome. This antiseptic action does not typically result in an externally observable patient symptom or feeling that signals it is working.

Q: Does Microgard contain any common allergens like gluten or lactose?

Regulatory documents list all inactive ingredients (excipients), which may include components that are common allergens, such as parabens or cetostearyl alcohol. You can check the specific excipients on the official product label.

Q: Can Microgard be stopped suddenly, or does it require a tapering schedule?

Given its minimal systemic absorption and no documented risks of dependence or withdrawal, a tapering schedule is not necessary. The use of this topical antiseptic can be stopped suddenly if it is no longer clinically required.

Q: Are there any specific organs Microgard is known to put stress on?

Regulatory documents detail that use is strictly prohibited near the eyes, the middle ear, and the central nervous system (meninges, brain, spinal cord). This prohibition is due to specific risks of injury documented for these sensitive anatomical areas.

Q: Why do official sources sometimes use the generic name instead of Microgard?

Official documents prioritize the use of the generic names (Chlorhexidine Gluconate and Cetrimide) because these refer to the active ingredients. The generic names are medically recognized across all brands and preparations containing the same components.

Q: Is Microgard considered safe for women who are planning a pregnancy?

Official labeling notes there are no adequate data available for safe use in pregnant women and reports no documented evidence that the active ingredients affect fertility.

How should Microgard be stored and disposed of?

How to Store and Dispose of Microgard

Official regulatory documents specify mandatory conditions for the storage and disposal of Microgard topical solution (Chlorhexidine Gluconate and Cetrimide) to maintain its quality and ensure safety.


Storage Requirements

Condition Requirement
Temperature Store below 30 C (86 F); Do not refrigerate or freeze the solution.
Protection Keep away from direct heat and light; store in a well-sealed container.
Child Safety Keep the product out of the sight and reach of children.
Stability Any unused solution or dilutions must be discarded after the period specified on the label.

Disposal Instructions

Unused or expired solution and its container must be disposed of in accordance with local regulations for pharmaceutical waste. Care must be taken during the disposal process to not contaminate water with the product.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Microgard found in:

A-Z Index: